Ginsenoside Rg1 ameliorates hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and inflammation by regulating CCN1-Reference-Cited by-同舟云学术

Ginsenoside Rg1 ameliorates hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and inflammation by regulating CCN1

Published:2023-08 Issue: Volume:164 Page:114920
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Tang Bai-lin,Liu Yu,Zhang Jing-liang^ORCID,Lu Mei-li,Wang Hong-xin

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference43 articles.

1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension;Simonneau;Eur. Respir. J.,2019

2. Paeoniflorin ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition;Yu;Drug Des. Dev. Ther.,2020

3. Magnesium lithospermate B ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and its potential targets;Wang;Biomed. Pharmacother.,2020

4. Pulmonary arterial hypertension: pathogenesis and clinical management;Thenappan;BMJ,2018

5. Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways;Rowan;Lancet Respir. Med.,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenoside Rg1 alleviates vascular remodeling in hypoxia-induced pulmonary hypertension mice through the calpain-1/STAT3 signaling pathway;Journal of Ginseng Research;2024-07

2. Ginsenoside Rg1 Suppresses Pyroptosis via the NF-κB/NLRP3/GSDMD Pathway to Alleviate Chronic Atrophic Gastritis In Vitro and In Vivo;Journal of Agricultural and Food Chemistry;2024-06-10

3. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling;Drug Design, Development and Therapy;2024-03

4. Triptolide attenuates cardiac remodeling by inhibiting pyroptosis and EndMT via modulating USP14/Keap1/Nrf2 pathway;Heliyon;2024-01

5. TGF‐β/Smads signaling pathway, Hippo‐YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases;Immunity, Inflammation and Disease;2023-11